Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data

Bioinformatics

Volumn 21, Issue 20, 2005, Pages 3905-3911

  Xu, Lei ^a,b   Tan, Aik Choon ^a,b   Naiman, Daniel Q ^a,b,c   Geman, Donald ^a,b,c   Winslow, Raimond L ^a,b  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEPSIN; SERINE PROTEINASE; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANALYTICAL ERROR; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; MALE; MARKER GENE; MATHEMATICAL COMPUTING; MOLECULAR STABILITY; PRIORITY JOURNAL; PROSTATE CANCER; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 27544492493     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/bti647     Document Type: Article

References (34)

1. Alizadeh,A.A. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
2. Bittner,M. et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406, 536-540.
3. Brawer,M.K. (1999) Prostate-specific antigen: Current status. CA A Cancer J. Clinicians, 49, 264-281.
4. Calo,V. et al. (2003) STAT proteins: From normal control of cellular events to tumorigenesis. J. Cell. Physiol., 197, 157-168.
5. Catalona,W.J. et al. (1997) Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: enhancement of specificity with free PSA measurement. J. Am. Med. Assoc., 277, 1452-1455.
6. Choi,J.K. et al. (2003) Combining multiple microarray studies and modeling interstudy variation. Bioinformatics, 19, 84i-90.
7. Dhanasekaran,S.M. et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature, 412, 822-826.
8. Dunn,G.P. et al. (2002) Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol., 3, 991-998.
9. Geman,D. et al. (2004) Classifying gene expression profiles from pairwise mRNA comparison. Stat. Appl. Genet. Mol. Biol., 3, 19.
10. Golub,T.R. et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
11. Jiang,H. et al. (2004) Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics, 5, 81.
12. Klezovitch,O. et al. (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell, 6, 185.
13. Kuo,W.P. et al. (2002) Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics, 18, 405-412.
14. Lai,Y. et al. (2004) A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics, 20, 3146-3155.
15. Lapointe,J. et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA, 101, 811-816.
16. LaTulippe,E. et al. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res., 62, 4499-4506.
17. Luo,J. et al. (2001) Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res., 61, 4683-4688.
18. Magee,J.A. et al. (2001) Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res., 61, 5692-5696.
19. Mah,N. et al. (2004) A comparison of oligonucleotide and cDNA-based microarray systems. Physiol. Genomics, 16, 361-370.
20. Mukherjee,S. et al. (2003) Estimating dataset size requirements for classifying DNA microarray data. J. Comput. Biol., 10, 119-142.
21. Nelson,P.S. (2004) Predicting prostate cancer behavior using transcript profiles. J. Urol., 172, S28-S33.
22. Ni,Z. et al. (2002) Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J. Urol., 167, 1859-1862.
23. O'Shea,J.J. et al. (2002) Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell, 109, S121-S131.
24. Rhodes,D.R. et al. (2002) Meta-Analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res., 62, 4427-4433.
25. Rhodes,D.R. et al. (2004) ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia, 6, 1-6.
26. Sakakura,C. et al. (2002) Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br. J. Cancer, 87, 1153-1161.
27. Shen,R. et al. (2004) Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data. BMC Genomics, 5, 94.
28. Singh,D. et al. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell, 1, 203.
29. Stamey,T.A. et al. (2001) Molecular genetic profiling of Gleason grade 4/ 5 prostate cancers compared to benign prostatic hyperplasia. J. Urol., 166, 2171-2177.
30. Stuart,R.O. et al. (2004) In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl Acad. Sci. USA, 101, 615-620.
31. Takahashi,M. et al. (2001) Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification. Proc. Natl Acad. Sci. USA, 98, 9754-9759.
32. Tibshirani,R. et al. (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl Acad. Sci. USA, 99, 6567-6572.
33. Terabe,M. et al. (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol., 1., 515-520.
34. Welsh,J.B. et al. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61, 5974-5978.